Sort
51,593 grants matching “hepatitis”
Regulation of Hepatic Gluconeogenesis by the CREB:TORC2 Pathway
$672,667Marc R Montminy · Salk Institute For Biological Studies · R37 · FY2011 · DK
Regulation of Hepatic Gluconeogenesis by the CREB:TORC2 Pathway
$672,662Marc R Montminy · Salk Institute For Biological Studies · R37 · FY2012 · DK
Health Promotion Coaching/Vaccine for Homeless Parolees
$672,630Adeline M Nyamathi · University Of California Los Angeles · R01 · FY2009 · DA
FFA Metabolism in Different Types of Human Obesity
$672,547Michael D. Jensen · Mayo Clinic Rochester · R01 · FY2024 · DK
Development of JR-220 (4-Chlorobenzylidenamino-guanidine hydrochloride) as a medication for alcohol dependence
$672,530John M Littleton · Naprogenix, Inc · U44 · FY2017 · AA
Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving
$672,377David Wolinsky · Johns Hopkins University · R01 · FY2025 · AA
Obesity Brain Expression
$672,351Anita L Destefano · Boston University Medical Campus · R01 · FY2015 · DK
Soft drusen in rhesus macaques as a nonhuman primate model of early age-related macular degeneration
$672,319Glenn Yiu · University Of California At Davis · R01 · FY2025 · EY
Comparing the effects of pharmacological treatment for gestational diabetes on long-term maternal and child health outcomes
$672,314Monique Marie Hedderson · Kaiser Foundation Research Institute · R01 · FY2025 · DK
Extended-Release Naltrexone Opioid Treatment at Jail-to-Community Re-entry
$672,308Joshua D Lee · New York University School Of Medicine · U01 · FY2015 · DA
Probing the specificity and activity of the metazoan Integrator complex
$672,280Karen L Adelman · Harvard Medical School · R01 · FY2019 · GM
Long-term Effects of IDU, HIV, HCV and the Impact of HCV Cure on Immune Activation and Liver Fibrosis in Aging Women
$672,140Andrea A. Kovacs · University Of Southern California · R01 · FY2021 · DA
Therapeutic Strategies for the Management of HCV/HIV co- infection
$672,108Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Determinants of Coronavirus Fidelity in Replication and Pathogenesis
$672,084Mark R Denison · Vanderbilt University Medical Center · R01 · FY2022 · AI
Determinants of Coronavirus Fidelity in Replication and Pathogenesis
$672,084Mark R Denison · Vanderbilt University Medical Center · R01 · FY2021 · AI
Determinants of Coronavirus Fidelity in Replication and Pathogenesis
$672,084Mark R Denison · Vanderbilt University Medical Center · R01 · FY2020 · AI
Determinants of Coronavirus Fidelity in Replication and Pathogenesis
$672,084Mark R Denison · Vanderbilt University Medical Center · R01 · FY2019 · AI
Angiotensin II Receptors And Signaling Mechanisms
$672,058Kevin J Catt · Child Health And Human Development · Z01 · FY2007 · HD
Nutritional Status In HIV Hispanic Drug Abusers
$671,959Janet E Forrester · Tufts University Boston · R01 · FY2007 · DA
The Impact of Pharmaceutical Industry Messaging on the Opioid Crisis among U.S. Military Veterans
$671,958Christopher Keith Haddock · Ndri-Usa, Inc. · R01 · FY2023 · DA
Paneth cells-derived IL-17A and liver ischemia reperfusion injury
$671,949H. Thomas Lee · Columbia University Health Sciences · R01 · FY2024 · DK
Telomerase in Development Senescence and Neoplasia
$671,830Ronald Anthony Depinho · Dana-Farber Cancer Inst · R01 · FY2010 · CA
Development of caspase-6 inhibitors for treatment of NASH
$671,821Alan R. Saltiel · University Of California, San Diego · R01 · FY2024 · DK
Metabolic Health during Puberty: the Healthy Start Study
$671,757Dana Dabelea · University Of Colorado Denver · R01 · FY2024 · DK
OVARIAN CANCER RISK AND HYPERGONADOTROPIC HYPOGONADISM
$671,708Brigham And Women'S Hospital · R01 · FY2000 · CA